MoneyWorks4Me

Lasa Supergenerics informs about certificate

25 Oct 2019 Evaluate

Lasa Supergenerics has informed that pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 the Company has submitted certificate from Amit R. Dadheech & Associates, Company Secretaries for the half year ended September 30, 2019.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..